Literature DB >> 23319588

An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1.

Zhiqiang Zheng1, Aimin Li, Brandon B Holmes, Jayne C Marasa, Marc I Diamond.   

Abstract

Huntington disease is a dominantly inherited neurodegenerative condition caused by polyglutamine expansion in the N terminus of the huntingtin protein (Htt). The first 17 amino acids (N17) of Htt play a key role in regulating its toxicity and aggregation. Both nuclear export and cytoplasm retention functions have been ascribed to N17. We have determined that N17 acts as a nuclear export sequence (NES) within Htt exon and when fused to yellow fluorescent protein. We have defined amino acids within N17 that constitute the nuclear export sequence (NES). Mutation of any of the conserved residues increases nuclear accumulation of Htt exon 1. Nuclear export of Htt is sensitive to leptomycin B and is reduced by knockdown of exportin 1. In HEK293 cells, NES mutations decrease overall Htt aggregation but increase the fraction of cells with nuclear inclusions. In primary cultured neurons, NES mutations increase nuclear accumulation and increase overall aggregation. This work defines a bona fide nuclear export sequence within N17 and links it to effects on protein aggregation. This may help explain the important role of N17 in controlling Htt toxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319588      PMCID: PMC3585045          DOI: 10.1074/jbc.M112.413575

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Biologically active molecules that reduce polyglutamine aggregation and toxicity.

Authors:  Urvee A Desai; Judit Pallos; Aye Aye K Ma; Brent R Stockwell; Leslie Michels Thompson; J Lawrence Marsh; Marc I Diamond
Journal:  Hum Mol Genet       Date:  2006-05-23       Impact factor: 6.150

2.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.

Authors:  Leslie Michels Thompson; Charity T Aiken; Linda S Kaltenbach; Namita Agrawal; Katalin Illes; Ali Khoshnan; Marta Martinez-Vincente; Montserrat Arrasate; Jacqueline Gire O'Rourke; Hasan Khashwji; Tamas Lukacsovich; Ya-Zhen Zhu; Alice L Lau; Ashish Massey; Michael R Hayden; Scott O Zeitlin; Steven Finkbeiner; Kim N Green; Frank M LaFerla; Gillian Bates; Lan Huang; Paul H Patterson; Donald C Lo; Ana Maria Cuervo; J Lawrence Marsh; Joan S Steffan
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

3.  The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.

Authors:  Fred Schaufele; Xavier Carbonell; Martin Guerbadot; Sabine Borngraeber; Mark S Chapman; Aye Aye K Ma; Jeffrey N Miner; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

4.  Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Authors:  Caroline L Benn; Christian Landles; He Li; Andrew D Strand; Ben Woodman; Kirupa Sathasivam; Shi-Hua Li; Shabnam Ghazi-Noori; Emma Hockly; Syed M N N Faruque; Jang-Ho J Cha; Paul T Sharpe; James M Olson; Xiao-Jiang Li; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-09-23       Impact factor: 6.150

5.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.

Authors:  Erica Rockabrand; Natalia Slepko; Antonello Pantalone; Vidya N Nukala; Aleksey Kazantsev; J Lawrence Marsh; Patrick G Sullivan; Joan S Steffan; Stefano L Sensi; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

6.  Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation.

Authors:  Jieya Shao; William J Welch; Nicholas A Diprospero; Marc I Diamond
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

7.  ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation.

Authors:  Jieya Shao; William J Welch; Marc I Diamond
Journal:  FEBS Lett       Date:  2008-04-16       Impact factor: 4.124

8.  Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.

Authors:  Randy Singh Atwal; Jianrun Xia; Deborah Pinchev; Jillian Taylor; Richard M Epand; Ray Truant
Journal:  Hum Mol Genet       Date:  2007-08-18       Impact factor: 6.150

9.  Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.

Authors:  Ashwani K Thakur; Murali Jayaraman; Rakesh Mishra; Monika Thakur; Veronique M Chellgren; In-Ja L Byeon; Dalaver H Anjum; Ravindra Kodali; Trevor P Creamer; James F Conway; Angela M Gronenborn; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2009-03-08       Impact factor: 15.369

10.  Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr.

Authors:  Iris Ben-Efraim; Phyllis D Frosst; Larry Gerace
Journal:  BMC Cell Biol       Date:  2009-10-16       Impact factor: 4.241

View more
  38 in total

1.  Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach.

Authors:  Matthias Michalek; Evgeniy S Salnikov; Burkhard Bechinger
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

2.  Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation.

Authors:  Scott L Crick; Kiersten M Ruff; Kanchan Garai; Carl Frieden; Rohit V Pappu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 3.  The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.

Authors:  James R Arndt; Maxmore Chaibva; Justin Legleiter
Journal:  Biomol Concepts       Date:  2015-03

Review 4.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

5.  Nucleation Inhibition of Huntingtin Protein (htt) by Polyproline PPII Helices: A Potential Interaction with the N-Terminal α-Helical Region of Htt.

Authors:  James R Arndt; Maxmore Chaibva; Maryssa Beasley; Ahmad Kiani Karanji; Samaneh Ghassabi Kondalaji; Mahdiar Khakinejad; Olivia Sarver; Justin Legleiter; Stephen J Valentine
Journal:  Biochemistry       Date:  2019-12-20       Impact factor: 3.162

Review 6.  Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.

Authors:  C Y Daniel Lee; Jeffrey P Cantle; X William Yang
Journal:  FEBS J       Date:  2013-07-31       Impact factor: 5.542

7.  Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.

Authors:  Robert O'Brien; Francesco DeGiacomo; Jennifer Holcomb; Akilah Bonner; Karen L Ring; Ningzhe Zhang; Khan Zafar; Andreas Weiss; Brenda Lager; Birgit Schilling; Bradford W Gibson; Sylvia Chen; Seung Kwak; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2015-05-29       Impact factor: 5.157

8.  Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations.

Authors:  Sébastien Côté; Vincent Binette; Evgeniy S Salnikov; Burkhard Bechinger; Normand Mousseau
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

9.  Free-Energy Landscape of the Amino-Terminal Fragment of Huntingtin in Aqueous Solution.

Authors:  Vincent Binette; Sébastien Côté; Normand Mousseau
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

10.  Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.

Authors:  Maxmore Chaibva; Sudi Jawahery; Albert W Pilkington; James R Arndt; Olivia Sarver; Stephen Valentine; Silvina Matysiak; Justin Legleiter
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.